Dudediligence.

Oragenics, Inc

OGENAMEX · Pharmaceutical Preparations
Write an idea

Price
FilingsNewest: 8-K, Regulation FD disclosureSep 16 →InsidersNo open-market buys. 1 insider sold $197 in 1 sale, with no 10b5-1 plan named.→Financing →

From the filings

Figures

Net income
−$10.1Mlast 12 months
Operating cash flow
−$9.3Mlast 12 months
Cash and equivalents
$3.9Mat the last balance sheet
Shares outstanding
4.5M shareson issue
Every year and quarter →